Brief: Avrobio Reports Third Quarter Financial Results
Nov 8 (Reuters) - AVROBIO Inc AVRO.O :
* AVROBIO REPORTS THIRD QUARTER 2022 FINANCIAL RESULTS AND
PROVIDES BUSINESS UPDATE
* AVROBIO - BASED ON CURRENT OPERATING PLAN, SEES CASH, CASH
EQUIVALENTS AS OF SEPT 30, TO ENABLE TO FUND OPERATING EXPENSES,
CAPEX REQUIREMENTS INTO Q1 2024
* AVROBIO INC QTRLY NET LOSS PER SHARE - BASIC AND DILUTED
$0.52
Source text for Eikon: ID:nBw7QpkgPa
Further company coverage: AVRO.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Tectonic Therapeutic
See all newsTectonic Therapeutic Inc reports results for the quarter ended June 30 - Earnings Summary
Tectonic Therapeutic Q2 net loss widens on higher costs
Tectonic Therapeutic Inc expected to post a loss of $1.35 a share - Earnings Preview
Brief: Tectonic Therapeutic Completes Enrollment In Tx45 Apex Phase 2 Clinical Trial In Ph-Hfpef Patients
Tectonic Therapeutic Q1 net loss widens on higher R&D costs